Ocular immune privilege: A review

Clinical Eye and Vision Care

Volumn 12, Issue 3-4, 2000, Pages 97-106

  Koevary, Steven B ^a  

^a NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

Author keywords

ACAID; Blood ocular barrier; Collagen induced arthritis; Ocular immune privilege; Transforming growth factor beta

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; HYDROCORTISONE; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE;

AQUEOUS HUMOR; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD EYE BARRIER; HUMAN; IMMUNITY; IMMUNOPATHOLOGY;

EID: 0034548359     PISSN: 09534431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-4431(00)00041-2     Document Type: Article

References (81)

1. Die entwickelung der in grund versetzten lebenden gewebe Albrecht von Graefes
2. Ueber das schicksal der in den organismus implantirten gewebe
3. Immunologically privileged sites
4. Immunoregulatory mechanisms of the eye
5. A new site for islet transplantation - A peritoneal omental pouch
6. Immune privilege in the retina
7. Transport of ions and metabolites across the endothelium
8. The role of HLA in corneal transplantation
9. Studies of complexes between proteases, substrates and the protease inhibitor alpha-2-macroglobulin using capillary electrophoresis with laser-induced fluorescence detection
10. Regional immunology of the eye
11. Assessment of blood-retinal barrier integrity
12. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis
13. The hamster cheek pouch: An immunologically privileged site suitable to the study of granulomatous infection
14. The role of ciliary blood flow and ultrafiltration in aqueous humor formation
15. CD4 T cells in submandibular lymph nodes after antigen injection in the anterior chamber may contribute to ACAID induction
16. Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body
17. Morphologic and ultrastructural examination of I-A+ cells in the murine iris
18. Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: Distribution, phenotype and relation to retinal microglia
19. Immunomorphologic studies of macrophages and MHC class II positive dendritic cells in the iris and ciliary body of the rat mouse and human eye
20. Distinctive distribution of bone marrow derived cells in the anterior segment of human eyes
21. Human retinal microglia express phenotypic characteristics in common with dendritic antigen-presenting cells
22. Organ-resident, non-lymphoid cells suppress proliferation of autoimmune T-helper lymphocytes
23. Corneal allografts fail to express Ia antigens
24. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-I secretion and migration of Langerhans cells into the central cornea
25. Corneal Langerhans cells migration following ocular contact sensitivity
26. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulation corneas
27. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation
28. Growth factors in aqueous humor or normal and inflamed eyes of rabbits
29. Inhibition of lymphocyte proliferation by aqueous humor
30. Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta
31. Transforming growth factor-betas are equipotent growth inhibitors of interleukin-1 induced thymocyte proliferation
32. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell function
33. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes
34. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha
35. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice
36. Effects of transforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
37. Transforming growth factor-β2 downregulates HLA-DR antigen expression on human malignant glioma cells
38. Transforming growth factor beta-1 and beta-2 in human tear fluid
39. Transforming growth factor-β in human aqueous humor
40. Aqueous humor contains transforming growth factor-beta and a small (< 3500 daltons) inhibitor of thymocyte proliferation
41. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor
42. Dual effect of ciliary body cells on T lymphocyte proliferation
43. Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells
44. Identification of transforming growth factor-β expressed in cultured human retinal pigment epithelial cells
45. Immunolocalization of TGF-β1, TGF-β2, and TGF-β3 in the anterior segment of the human eye
46. Distribution of transforming growth factor-beta isoforms in the mammalian retina
47. Fas ligand-induced apoptosis as a mechanism of immune privilege
48. The fas-fas ligand system and other modulators of apoptosis in the cornea
49. Proinflammatory function of FAS ligand on corneal endothelial cells is regulated by aqueous humor
50. Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation
51. Studies on the induction of ACAID. II. Eye-derived cells participate in generating blood-borne signals that induce ACAID
52. Characterization of suppressor cells in ACAID induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations
53. Suppression of experimental autoimmune uveitis in mice by induction of ACAID with interphotoreceptor retinoid-binding protein
54. ACAID induced by TNP-splenocytes
55. ACAID requires early replication of HSV-1 in the injected eye
56. Role of splenic B cells in the immune privilege of the anterior chamber of the eye
57. Characterization of specific T helper cell activity in mice bearing alloantigenic tumors in the anterior chamber of the eye
58. Deviant immune responses to allogenic tumors injected intracamerally and subcutaneously in mice
59. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens
60. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses
61. Characterization of the suppressor cells responsible for ACAID induced in BALB/c mice by P815 cells
62. Distinctive humoral responses following anterior chamber and intravenous administration of soluble antigen: Evidence for active suppression of IgG2a-secreting B cells
63. The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum
64. Studies on the induction of ACAID. I. Evidence that an antigen-specific, ACAID-inducing, cell associated signal exists in the peripheral blood
65. Induction of ACAID requires an intact functional spleen
66. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products
67. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type
68. Fluid from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving TGF-β
69. Studies on the induction of ACAID. III. Induction of anterior chamber-associated immune deviation depends upon intraocular transforming growth factor beta
70. In vitro-ACAID induction by culturing blood monocytes with transforming growth factor-beta
71. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation
72. A novel role for TGF-β and IL-10 in the induction of immune privilege
73. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells
74. Molecular basis of ACAID
75. Regulation of ocular immune responses
76. The immune response and the eye TCR α-chain related molecules regulate the systemic immunity to antigen presented in the eye
77. Immune regulation and the eye: A dangerous compromise
78. Effects of corneal surgical wounds on ocular immune privilege
79. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber associated immune deviation with interphotoreceptor retinoid binding protein
80. Ocular injection of retinal S antigen: Suppression of autoimmune uveitis
81. Prevention of diabetes in BB/Wor rats by injection of peritoneal exudate cells cultured in the presence of transforming growth factor beta TGF-β and islet cells